Outlook Therapeutics Inc (OTLK) Company Profile & Statistics

Outlook Therapeutics Inc
OTLK
(Nasdaq - US)
Open
5.09
-0.04 (-0.78%)
in:usd•As of: Nov 22, 2024 13:26 UTC -5
Open
5.12
High
5.18
Low
4.99

About Outlook Therapeutics Inc

CEO

C. Russell Trenary

Headquarters

485 route 1 south, building f, suite 320

iselin, nj 08852, united states

Auditor

KPMG LLP

Employees

Share Holders

Website

www.outlooktherapeutics.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Outlook Therapeutics Inc. is a clinical-stage biopharmaceutical company. It focuses on developing ONS-5010 which is a proprietary ophthalmic bevacizumab product candidate for the treatment of wet age related macular degeneration which is in clinical stage. Outlook Therapeutics Inc., formerly known as Oncobiologics Inc., is based in Cranbury, United States.

Outlook Therapeutics Inc Statistics

Valuation Measures

Market Capitalization ²	120.43M
Enterprise Value	120.84M
Enterprise Value/EBITDA (ttm)	-1.97
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	N/A
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	N/A
Return on Invested Capital (ttm)	167.96%
Return on Assets (ttm)	-160.88%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-61.19M
Net Income Avi to Common (ttm)	-94.05M
Diluted EPS (ttm)	-10.70

Share Statistics

Beta (5Y Monthly)	0.62
52-Week Change	-42.17%
S&P500 52-Week Change	30.96%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	23.66M
Dividend Yield	0.00%
Float ⁴	22.85M
% Held by Insiders	3.40%
% Held by Institutions	11.20%

Balance Sheet

Total Cash (mrq)	32.02M
Total Cash Per Share (mrq)	1.35
Total Debt (mrq)	32.43M
Total Debt/Equity (mrq)	-38.76%
Current Ratio (mrq)	1.07%
Quick Ratio (mrq)	1.07%
Book Value Per Share (mrq)	-3.57

Cash Flow

Operating Cash Flow Per Share (ytd)	-2.03
Free Cash Flow (ytd)	-51.81M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Outlook Therapeutics Inc

Trade With A Regulated Broker